PSG.DE Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 apr 2024 @ 17:36):

Stats
Dagens volum	179.00
Gjennomsnittsvolum	516.00
Markedsverdi	266.18M
EPS	€0 ( 2024-04-07 )
Neste inntjeningsdato	( €0 ) 2024-06-26
Last Dividend	€0.490 ( 2023-06-29 )
Next Dividend	€0 ( N/A )
P/E	17.76
ATR14	€0 (0.00%)

PharmaSGP Holding SE Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

PharmaSGP Holding SE Økonomi

Annual	2022
Omsetning:	€85.82M
Bruttogevinst:	€76.79M (89.48 %)
EPS:	€1.000

FY	2022
Omsetning:	€85.82M
Bruttogevinst:	€76.79M (89.48 %)
EPS:	€1.000

Financial Reports:

No articles found.

PharmaSGP Holding SE Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
€0 (N/A)	€0 (N/A)	€0 (N/A)	€0.490 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)

PharmaSGP Holding SE Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.91 - Stable (1.77%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	€0.450	2022-06-16
Last Dividend	€0.490	2023-06-29
Next Dividend	€0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	2	--
Total Paid Out	€0.940	--
Avg. Dividend % Per Year	0.00%	--
Score	3	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	4.91
Div. Directional Score	8.25	--

Next Divdend (Est)
(2025-03-31)

€0.393 Estimate 3.00 %

Dividend Stability

0.24 Very Poor

Dividend Score

3.00

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for XETRA

Symbol	Title	Last dividend	Frequency	Yearly Dividend
UNH.DE	Ex Dividend Knight	2023-09-08	Quarterly	0.00%
EFE.F	Ex Dividend Junior	2023-05-10	Annually	0.00%
NKE.DE	Ex Dividend Knight	2023-09-01	Quarterly	0.00%
AEND.DE	Ex Dividend Junior	2023-08-29	Semi-Annually	0.00%
YSN.DE	Ex Dividend Knight	2023-06-01	Annually	0.00%
GIL.DE	Ex Dividend Junior	2023-05-15	Annually	0.00%
PNE3.DE	No Dividend Player	2023-05-10	Annually	0.00%
BIRG.DE	Ex Dividend Junior	2023-05-11	Sporadic	0.00%
I93.F	Ex Dividend Junior	2023-08-28	Quarterly	0.00%
SLL.DE	Ex Dividend Junior	2023-05-23	Sporadic	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.154	1.500	6.93	10.00	[0 - 0.5]
returnOnAssetsTTM	0.114	1.200	6.20	7.44	[0 - 0.3]
returnOnEquityTTM	0.451	1.500	6.10	9.15	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	2.56	0.800	2.21	1.766	[1 - 3]
quickRatioTTM	2.05	0.800	2.66	2.13	[0.8 - 2.5]
cashRatioTTM	1.546	1.500	2.52	3.78	[0.2 - 2]
debtRatioTTM	0.00766	-1.500	9.87	-10.00	[0 - 0.6]
interestCoverageTTM	5.89	1.000	8.93	8.93	[3 - 30]
operatingCashFlowPerShareTTM	2.18	2.00	9.27	10.00	[0 - 30]
freeCashFlowPerShareTTM	2.12	2.00	8.94	10.00	[0 - 20]
debtEquityRatioTTM	0.0275	-1.500	9.89	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.906	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	0.246	1.000	7.08	7.08	[0.1 - 0.6]
cashFlowToDebtRatioTTM	25.94	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0.742	0.800	8.39	6.71	[0.5 - 2]
Total Score				11.60

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	17.76	1.000	8.31	0	[1 - 100]
returnOnEquityTTM	0.451	2.50	7.49	9.15	[0.1 - 1.5]
freeCashFlowPerShareTTM	2.12	2.00	9.29	10.00	[0 - 30]
dividendYielPercentageTTM	2.21	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	2.18	2.00	9.27	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.268	1.000	5.81	0	[0.1 - 0.5]
Total Score				4.91

PharmaSGP Holding SE

PharmaSGP Holding SE manufactures over-the-counter drugs, and other healthcare products in Germany. The company's pharmaceutical products include Baldriparan for the treatment of sleep disorders; Spalt, Formigran, and Kamol massage cream for the treatment of different pain conditions; RubaXX pharmaceutical drops for the treatment of rheumatic pain in bones, tendons, and muscles; Restaxil pharmaceutical drops for the treatment of nerve pain in neck and back; Fulminan, a beauty drink for problems in areas, such as eye area, buttocks, or thighs; DESEO pharmaceutical drops for sexual weakness; Neradin, a drug for sexual dysfunction; and TAUMEA, a drug for the treatment of vertigo. It also offers products for the treatment of chronic indications, including pain and other age-related ailments. The company sells its products through pharmacies and wholesalers. It exports its products to European countries comprising Austria, Italy, Belgium, Spain, and France. The company was founded in 2012 and is based in Gräfelfing, Germany.